Drug Profile
M 3000
Alternative Names: M-3000Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator SyndromeX
- Class Anti-inflammatories; Antineoplastics
- Mechanism of Action AMP activated protein kinase modulators; FOXO1 protein expression modulators; Hepatocyte nuclear factor 4 modulators; Mitochondrial permeability transition pore modulators; STAT3 transcription factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer; Inflammation
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Autoimmune disorders in Israel (PO) before September 2023
- 12 Sep 2023 Discontinued - Preclinical for Inflammation in Israel (PO) before September 2023
- 12 Sep 2023 Discontinued for Cancer in Israel (PO) before September 2023